Investor Presentaiton

Strong Customer Focus Drives Market Share Gains SUN PHARMA Therapy focused marketing 9,200+ sales representatives Covering over 600,000* doctors Strong increase in market share Sun pharma market share has consistently increased from 2.4% in 2000 to 8.0% in 2017 (IMS Data for March'18) * Does not exclude overlaps Market Share (%) as per IMS Dec MAT Year -2000 % Year -2005 % Year -2010 % Year -2015 % Year -2017 % Sun Pharma 2.4 Sun Pharma 3.3 Sun Pharma 3.7 Sun Pharma 8.0 Sun Pharma 8.0 Cipla 4.7 Cipla 5.1 Cipla 5.4 Cipla 5.2 Cipla 5.2 Lupin 2.0 Lupin 2.2 Lupin 2.7 Lupin 3.2 Lupin 3.5 Cadila 3.8 Cadila 3.7 Cadila 3.7 Cadila 3.4 Cadila 3.2 DRL 2.6 DRL 2.3 DRL 2.3 DRL 2.4 DRL 2.2 Torrent 1.8 Torrent 1.9 Torrent 2.0 Torrent 2.4 Torrent 3.3 Glenmark 1.0 Glenmark 1.2 Glenmark 1.5 Glenmark 2.0 Glenmark 2.2 Wockhardt 2.2 Wockhardt 1.9 Wockhardt 2.0 Wockhardt 1.6 Wockhardt 1.5 Ipca 1.1 Ipca 1.3 Ірса 1.4 Ipca 1.5 Ipca 1.5 Ranbaxy 4.8 Ranbaxy 4.9 Ranbaxy 4.9 Unichem 1.0 FDC 1.0 © Sun Pharmaceutical Industries Limited. All Rights Reserved. 24

View entire presentation